Multiple Patients Dosed in Topical Phase I/II Clinical Trial
Highlights:
• Multiple Patients Dosed in Phase I/II clinical trial, an important human clinical
milestone
• No adverse symptoms reported - R327 well stocked in hospital pharmacy for further
patient utilisation
• Interim data readouts expected this quarter with full data end CY Q4 2021
No adverse symptoms reported !!!!
Go RECCE!!!
Ann: Multiple Patients Dosed in Topical Phase I/II Clinical Trial, page-3
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
65.0¢ |
Change
0.010(1.56%) |
Mkt cap ! $132.5M | |||
| Open | High | Low | Value | Volume |
| 64.5¢ | 65.5¢ | 64.5¢ | $26.17K | 40.36K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10615 | 65.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 65.5¢ | 6974 | 1 |
View Market Depth
| Last trade - 16.10pm 13/05/2024 (20 minute delay) ? |
|
|||||
|
Last
65.0¢ |
Change
0.010 ( 1.56 %) |
||||
| Open | High | Low | Volume | ||
| 65.0¢ | 65.5¢ | 65.0¢ | 1745 | ||
| Last updated 14.58pm 13/05/2024 ? | |||||
| RCE (ASX) Chart |